Literature DB >> 4314379

Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

J N Wilfert, F F Barrett, W H Ewing, M Finland, E H Kass.   

Abstract

The biochemical, serological, and epidemiological characteristics of 95 strains of Serratia marcescens isolated at the Boston City Hospital were examined. Several strains were shown to be endemic, and the majority of isolates were cultured from urine or respiratory secretions. Serratia species were highly resistant to polymyxin B and the cephalosporins, and various proportions were also resistant to other antibiotics including kanamycin, but all of the isolates were sensitive to gentamicin. The appearance of resistance to kanamycin and nalidixic acid among endemic strains was demonstrated. The nosocomial nature of Serratia infections, particularly those involving the urinary tract, was confirmed. Many clinical bacteriology laboratories currently fail to identify the nonpigmented strains.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4314379      PMCID: PMC376681          DOI: 10.1128/am.19.2.345-352.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  29 in total

1.  LIPOLYTIC, PECTOLYTIC, AND ALGINOLYTIC ACTIVITIES OF ENTEROBACTERIACEAE.

Authors:  B R DAVIS; W H EWING
Journal:  J Bacteriol       Date:  1964-07       Impact factor: 3.490

2.  1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors:  G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal:  J Med Pharm Chem       Date:  1962-09

3.  SELDOM-ENCOUNTERED AGENTS OF BACTERIAL MENINGITIS.

Authors:  C D GRABER; L S HIGGINS; J S DAVIS
Journal:  JAMA       Date:  1965-06-14       Impact factor: 56.272

4.  Identification of Serratia occurring in man and animals.

Authors:  M FULTON; C E FORNEY; E LEIFSON
Journal:  Can J Microbiol       Date:  1959-06       Impact factor: 2.419

5.  Asymptomatic infections of the urinary tract.

Authors:  E H KASS
Journal:  Trans Assoc Am Physicians       Date:  1956

6.  An outbreak of Serratia marcescens, and its control.

Authors:  H A Cabrera
Journal:  Arch Intern Med       Date:  1969-06

7.  Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.

Authors:  J R Tillotson; M Finland
Journal:  J Infect Dis       Date:  1969-06       Impact factor: 5.226

8.  [Epidemics of pleuro-pulmonary infections due to "Serratia marcescens" in a hospital environment].

Authors:  J C Burdin; J Lochard; F Schaack; M Edert; J C Georges
Journal:  Presse Med       Date:  1967-02-25       Impact factor: 1.228

9.  Nonpigmented Serratia marcescens.

Authors:  E Clayton; A Von Graevenitz
Journal:  JAMA       Date:  1966-09-26       Impact factor: 56.272

10.  Infections caused by nonpigmented Serratia. Report of seven cases.

Authors:  C W Magnuson; H R Elston
Journal:  Ann Intern Med       Date:  1966-09       Impact factor: 25.391

View more
  33 in total

1.  [Antibody detection in infections with Serratia marcescens (author's transl)].

Authors:  V Freitag; F H Caselitz
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Sensitivity of Citrobacter freundii and Citrobacter koseri to cephalosporins and penicillins.

Authors:  B Holmes; A King; I Phillips; S P Lapage
Journal:  J Clin Pathol       Date:  1974-09       Impact factor: 3.411

3.  Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  T Okuda; N Endo; Y Osada; H Zen-Yoji
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  A comparison of typing methods for Serratia marcescens.

Authors:  B Anderhub; T L Pitt; Y J Erdman; W R Willcox
Journal:  J Hyg (Lond)       Date:  1977-08

5.  Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1971-12

6.  Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.

Authors:  S Schaefler; J Winter; A Catelli; J Greene; B Toharski
Journal:  Appl Microbiol       Date:  1971-09

7.  Caprylate-thallous agar medium for selectively isolating Serratia and its utility in the clinical laboratory.

Authors:  M P Starr; P A Grimont; F Grimont; P B Starr
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

8.  Biotyping of Serratia marcescens and its use in epidemiological studies.

Authors:  P A Grimont; F Grimont
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

9.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

10.  R factor-mediated antibiotic resistance in Serratia marcescens.

Authors:  R C Cooksey; G M Thorne; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.